1 / 6

Global Aortic Valve Market – Analysis and Forecast (2018-2024)

The aortic valve is a valve between the left ventricle and aorta. It divides the heartu2019s key pumping chamber and the aorta that provides oxygen intense blood to the body. Aortic valve disease restricts blood flow and forces the heart to work tougher to supply blood to the rest of the body. Aortic valve stenosis, aortic valve regurgitation is the aortic valve diseases. It is treated with the procedures such as aortic valve repair and aortic valve replacement. These procedures help to restore normal blood flow, help to preserve the function of the heart muscles, and reduce symptoms.<br><br>The global aortic valve market is growing at a significant rate, due to the mounting occurrence of valvular diseases, and expanding programs for creating alertness about valve replacement. Different products such as a transcatheter aortic valve, sutureless aortic valve, and others contributed to the aortic valve market size. The market has witnessed high demand for transcatheter aortic valve due to a mounting number of clinical studies for enlarging their uses, mounting occurrence of cardiovascular diseases, and escalating initiatives for research activities.<br><br>Download Free Report Sample At: https://www.vynzresearch.com/healthcare/aortic-valve-market/request-sample<br><br>The mounting occurrence of valvular diseases, expanding the geriatric population, escalating healthcare expenditure, intensifying number of clinical trials, and expanding programs for creating alertness about valve replacement are the primary growth drivers for aortic valve market. For instance, according to the World Health Organization (WHO), globally in 2010 approximately 524 million people were aged 65 years and older and is expected to reach 1.5 billion in 2050.<br><br>Mounting inclination towards minimally invasive surgeries, escalating number of product launches and approvals, and favorable reimbursement scenario are also facilitating the growth for the aortic valve market.<br><br>Geographically, North America is the largest aortic valve market as in the region the healthcare expenditure is increasing. In addition, the mounting occurrence of valvular diseases, expanding the geriatric population, the presence of a large number of medical device manufacturers, and advanced reimbursement structure is also up surging growth of the North American aortic valve market.<br><br>Asia-Pacific is observed to witness the fastest growth in the market, due to the mounting occurrence of valvular diseases and the presence of a large number of the patient base with cardiovascular diseases. In addition, mounting healthcare expenditure, expanding geriatric population, mounting medical tourism, refining healthcare infrastructure, and escalating inclination towards minimally invasive surgery are also creating a positive impact on the aortic valve market growth in the region.<br><br>Read More: https://www.vynzresearch.com/healthcare/aortic-valve-market<br><br>Key players in the aortic valve market are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe. In June 2017, Edwards Lifesciences Corporation received FDA approval for aortic and mitral valve-in-valve procedures utilizing the Edwards SAPIEN 3 transcatheter heart valve. Boston Scientific Corporation, LivaNova Plc, Edwards Lifesciences Corporation, Abbott Laboratories, CryoLife Inc. and Medtronic plc are the key players offering aortic valve.<br><br>About VynZ Research<br>VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies.<br><br>Contact<br><br>Manager: Client Care<br><br>Toll-Free: 18882533960<br><br>Email: kundan@vynzresearch.com<br><br>Website: www.vynzresearch.com

Télécharger la présentation

Global Aortic Valve Market – Analysis and Forecast (2018-2024)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Global Aortic Valve Market

  2. About VynZ Research… • VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies. • VynZ Research has one of the most qualified & experienced analysts, who are constantly tracking the markets and the technologies. The research team has years of proven experience and wide knowledge & understanding of the technology, application, business models, and regulators of the segments and the value chain involved. • A trusted & proven methodology that involves highest quality of primary research, secondary analysis collated & verified through various sources including cross checking with different industry experts. • Serving wide range of customers most of them from Fortune 2000 companies • With a dedicated 24x7 customer helpline our customers can reach for specifying their needs • Developing long term relationship with the clients and satisfying them is one of the crucial notches of the company. VynZ Research aims at gaining and retaining its clients in order to make long term customer relationship.

  3. Global Aortic Valve Market The aortic valve is a valve between the left ventricle and aorta. It divides the heart’s key pumping chamber and the aorta that provides oxygen intense blood to the body. Aortic valve disease restricts blood flow and forces the heart to work tougher to supply blood to the rest of the body. Aortic valve stenosis, aortic valve regurgitation is the aortic valve diseases. It is treated with the procedures such as aortic valve repair and aortic valve replacement. These procedures help to restore normal blood flow, help to preserve the function of the heart muscles, and reduce symptoms.

  4. Global Aortic Valve Market The mounting occurrence of valvular diseases, expanding the geriatric population, escalating healthcare expenditure, intensifying number of clinical trials, and expanding programs for creating alertness about valve replacement are the primary growth drivers for aortic valve market. For instance, according to the World Health Organization (WHO), globally in 2010 approximately 524 million people were aged 65 years and older and is expected to reach 1.5 billion in 2050. Geographically, North America is the largest aortic valve market as in the region the healthcare expenditure is increasing. In addition, the mounting occurrence of valvular diseases, expanding the geriatric population, the presence of a large number of medical device manufacturers, and advanced reimbursement structure is also up surging growth of the North American aortic valve market.

  5. Global Aortic Valve Market Asia-Pacific is observed to witness the fastest growth in the market, due to the mounting occurrence of valvular diseases and the presence of a large number of the patient base with cardiovascular diseases. In addition, mounting healthcare expenditure, expanding geriatric population, mounting medical tourism, refining healthcare infrastructure, and escalating inclination towards minimally invasive surgery are also creating a positive impact on the aortic valve market growth in the region. In June 2017, Edwards Lifesciences Corporation received FDA approval for aortic and mitral valve-in-valve procedures utilizing the Edwards SAPIEN 3 transcatheter heart valve. Boston Scientific Corporation, LivaNova Plc, Edwards Lifesciences Corporation, Abbott Laboratories, CryoLife Inc. and Medtronic plc are the key players offering aortic valve.

  6. For Sample Report :- https://www.vynzresearch.com/healthcare/aortic-valve-market/request-sample www.vynzresearch.com

More Related